Validation study on sleep-improvement effects by test-food intakes - Validation study on sleep-improvement effects by test-food intakes

CPCC Company Limited0 sites140 target enrollmentMarch 6, 2023

ConditionsHealthy male/female subjects

Overview

Phase: 未知
Intervention: Not specified
Conditions: Healthy male/female subjects
Sponsor: CPCC Company Limited
Enrollment: 140
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

March 6, 2023

End Date

July 2, 2023

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

CPCC Company Limited

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•Subjects \- \- (1\) taking in sleep\-affecting foods (e.g., GABA), not less than three times a week, (2\) who will take medicines which might affect the test (e.g., sleeping pill) during the test period, (3\) with insomnia, sleep\-apnea syndrome, restless legs one, overactive cystitis, reflux esophagitis, (4\) with affecting rhinitis or pollinosis, (5\) with a pacemaker, (6\) with an alcohol intake during the test period, (7\) having a habit of smoking, (8\) with previous medical history of mental disorder, (9\) with abnormal carbohydrate metabolism at pre\-test 1, (10\) with medical history of serious diseases (e.g., cardiac), (11\) with extremely irregular life rhythm, (12\) planning affecting life\-events during the test period, (13\) planning to go on a business/long/event trip during the brain\-wave measuring period, (14\) with night urinations, not less than twice a day, (15\) cannot use a bedding by themselves, (16\) who might be woken up by a roomer during sleep, (17\) who have been diagnosed as dry mouth, (18\) with intraoral bleeding tendency, (19\) with pregnancy, possibly one, or lactating, (20\) with drug/food allergy, (21\) being under another clinical test (medicine or health food), or participated in that within the last 4 weeks, or will join that after the consent, (22\) who donated their blood components or blood (0\.2 L) within the last month, (23\) who donated his blood (0\.4 L) within the last 3 months, (24\) who donated her blood (0\.4 L) within the last 4 months, (25\) being collected in total of his blood (1\.2 L) within the last 12 months and in this study, (26\) being collected in total of her blood (0\.8 L) within the last 12 months and in this study, (27\) who break out in a rash from putting electrodes on the head and neck, (28\) being determined as ineligible for participation by the principal/sub investigator \- \- .